Largest companies by cash on hand
cash on hand
| Company | Cash on hand | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 101 | $113.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 102 | $112.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 103 | $111.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 104 | $110.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 105 | $110.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 106 | $109.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 107 | $99.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 108 | $99.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 109 | $98.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 110 | $98.49M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 111 | $96.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 112 | $96.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 113 | $95.38M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 114 | $92.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 115 | $92.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 116 | $89.13M | Healthcare | Pharmaceuticals | United States | NYSE |
| 117 | $86.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 118 | $86.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 119 | $85.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 120 | $82.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 121 | $82.49M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 122 | $79.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 123 | $79.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 124 | $79.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 125 | $76.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 126 | $73.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 127 | $73.83M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 128 | $72.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 129 | $72.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 130 | $71.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 131 | $70.24M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 132 | $70.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 133 | $68.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 134 | $67.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 135 | $67.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 136 | $65.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 137 | $64.22M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 138 | $63.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 139 | $63.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 140 | $63.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 141 | $63.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 142 | $63.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 143 | $62.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 144 | $61.42M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 145 | $57.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 146 | $56.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 147 | $56.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 148 | $55.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 149 | $55.00M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 150 | $54.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 151 | $54.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 152 | $54.12M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 153 | $54.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 154 | $53.43M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 155 | $52.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 156 | $50.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 157 | $50.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 158 | $49.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 159 | $48.49M | Healthcare | Pharmaceuticals | United States | NYSE |
| 160 | $48.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 161 | $46.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 162 | $45.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 163 | $45.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 164 | $44.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 165 | $44.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 166 | $44.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 167 | $44.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 168 | $43.18M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 169 | $42.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 170 | $42.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 171 | $41.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 172 | $41.42M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 173 | $41.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 174 | $41.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 175 | $41.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 176 | $39.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 177 | $37.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 178 | $36.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 179 | $33.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 180 | $33.42M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 181 | $33.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 182 | $32.29M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 183 | $31.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 184 | $28.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 185 | $27.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 186 | $27.60M | Healthcare | Pharmaceuticals | United States | NYSE |
| 187 | $27.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 188 | $26.90M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 189 | $26.84M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 190 | $26.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 191 | $26.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 192 | $26.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 193 | $26.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 194 | $25.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 195 | $25.42M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 196 | $24.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 197 | $24.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 198 | $24.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 199 | $24.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 200 | $24.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 317 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.